SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-24-031005
Filing Date
2024-02-12
Accepted
2024-02-12 07:01:22
Documents
157
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d600678d10k.htm   iXBRL 10-K 4076771
2 EX-10.23 d600678dex1023.htm EX-10.23 83314
3 EX-10.24 d600678dex1024.htm EX-10.24 5017
4 EX-21 d600678dex21.htm EX-21 7559
5 EX-23 d600678dex23.htm EX-23 2779
6 EX-31.1 d600678dex311.htm EX-31.1 10362
7 EX-31.2 d600678dex312.htm EX-31.2 10331
8 EX-32 d600678dex32.htm EX-32 4353
9 EX-97 d600678dex97.htm EX-97 26083
15 GRAPHIC g600678g0129214653895.jpg GRAPHIC 3243
16 GRAPHIC g600678g0129214903245.jpg GRAPHIC 2511
17 GRAPHIC g600678g29l02.jpg GRAPHIC 73056
  Complete submission text file 0001193125-24-031005.txt   21438421

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA teva-20231231.xsd EX-101.SCH 154147
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20231231_cal.xml EX-101.CAL 87633
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20231231_def.xml EX-101.DEF 930203
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20231231_lab.xml EX-101.LAB 991068
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20231231_pre.xml EX-101.PRE 998754
159 EXTRACTED XBRL INSTANCE DOCUMENT d600678d10k_htm.xml XML 4654993
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16174 | Film No.: 24617334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)